DE1618028A1 - Process for the preparation of methylacyloxymethyl ketals from prednisolone derivatives with 3 to 5 carbon atoms in the acyl group - Google Patents
Process for the preparation of methylacyloxymethyl ketals from prednisolone derivatives with 3 to 5 carbon atoms in the acyl groupInfo
- Publication number
- DE1618028A1 DE1618028A1 DE19671618028 DE1618028A DE1618028A1 DE 1618028 A1 DE1618028 A1 DE 1618028A1 DE 19671618028 DE19671618028 DE 19671618028 DE 1618028 A DE1618028 A DE 1618028A DE 1618028 A1 DE1618028 A1 DE 1618028A1
- Authority
- DE
- Germany
- Prior art keywords
- carbon atoms
- ketals
- methylacyloxymethyl
- acyl group
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000004432 carbon atom Chemical group C* 0.000 title claims description 10
- 238000000034 method Methods 0.000 title claims 5
- 125000002252 acyl group Chemical group 0.000 title description 5
- 150000003116 prednisolone derivatives Chemical class 0.000 title 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 239000011737 fluorine Substances 0.000 claims description 4
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 150000001887 cortisones Chemical class 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 150000002576 ketones Chemical class 0.000 claims 1
- 229960005294 triamcinolone Drugs 0.000 description 8
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000003246 corticosteroid Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010018691 Granuloma Diseases 0.000 description 3
- 150000001241 acetals Chemical class 0.000 description 3
- -1 butyroyloxyacetonide Chemical compound 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229940043075 fluocinolone Drugs 0.000 description 2
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- HGTYBQOCNLPOHZ-UHFFFAOYSA-N 2-oxopropyl hexanoate Chemical compound CCCCCC(=O)OCC(C)=O HGTYBQOCNLPOHZ-UHFFFAOYSA-N 0.000 description 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241001249696 Senna alexandrina Species 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 125000005257 alkyl acyl group Chemical group 0.000 description 1
- 229940051868 antimigraine drug corticosteroid derivative Drugs 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von Methyl acyl oxyinethylke tal en aus Prednisolonderi«* vaten mit 3—5 C-Atomen in der Acylgruppe.The present invention relates to a method for Production of methyl acyl oxyinethylketal en from Prednisolonderi «* vaten with 3-5 carbon atoms in the acyl group.
■■"":" ; - Γ ■ -. -:. ■ ■ j Es ist bekannt, Alkyl acyl oxy alkyl ketale aus Prednisolönderi- ■■ "" : "; - Γ ■ -. - :. ■ ■ j It is known that alkyl acyl oxy alkyl ketals from Prednisolönderi-
'.-■ : ■''-■■'■■ - - · -'■ ■■- '■■-."■"■"■ ν - i'.- ■ : ■''-■■' ■■ - - · - '■ ■■ -' ■■ -. "■" ■ "■ ν - i
vaten herzustellen. Diese Verbindungen zeigen einen guten jto produce fathers. These connections show a good j
antiinflaipmatorischen Effekt, insbesondere, wenn die Acylgruppeanti-inflammatory effect, especially when the acyl group
1-2 C-Atome enthält. Versuche mit anderen Acetalen und Ketälen haben ergeben, daß die Anzahl C-Atome in der Acetal-· und Ketal— gruppe niedrig sein sollte. Methylacyloxymethylketale bekannter Art sind u.a. in dem englischen Patent Nr. 1 020 309und dem belgischen Patent 660 5^9 beschrieben.Contains 1-2 carbon atoms. Try other acetals and ketals have shown that the number of carbon atoms in the acetal · and ketal- group should be low. Methylacyloxymethyl ketals better known Art are, inter alia, in English Patent No. 1 020 309 and the Belgian patent 660 5 ^ 9.
00984A/179300984A / 1793
iew. SKCHTZIEtMSNCHmiew. SKCHTZIEtMSNCHm
Eine langwierige Forschungsarbeit hat überraschend und im Gegensatz zu üblichen Erfahrungen mit Acetalen und Ketalen aus Cortisonderivaten erfindungsgemäß ergeben, daß eine höhere Anzahl C-Atome in der Acylgruppe des Ketals einen offenbar verbesserten antiinflammatorischen Effekt in Verhältnis zu dem antiinflammatorischen Effekt gibt, der mit Ketalen nach den erwähnten Patenten erhalten wird. Die Anzahl C-Atome in der Acylgruppe soll dabei mindestens 3 und höchstens 5 sein.A lengthy research has surprisingly and im In contrast to usual experiences with acetals and ketals from cortisone derivatives according to the invention show that a higher Number of carbon atoms in the acyl group of the ketal has an apparently improved anti-inflammatory effect in relation to that gives anti-inflammatory effect, which is obtained with ketals according to the patents mentioned. The number of carbon atoms in the The acyl group should be at least 3 and at most 5.
Die Verbindung nach vorliegender Erfindung hat nachstehende allgemeine Formel:The compound of the present invention has the following general formula:
HOHO
- O - C - R,- O - C - R,
00984V/179300984V / 1793
wobei IL eine Alkylgruppe ist t die wenigstens 3 C-Atome und höchstens 5 C-Atome hat, in der P Fluor bedeutet und X Wasserstoff oder Fluor,where IL is an alkyl group t has at least 3 carbon atoms and at most 5 carbon atoms, in which P denotes fluorine and X denotes hydrogen or fluorine,
Für die Herstellung der Verbindungen, die unter vorstehende
-Formel fallen, wird nur ein Beispiel angeführt» da. die übrigen
Verbindungen in genau der gleichen Weise hergestellt werden
können»
Beispiel 1 Only one example is given for the preparation of the compounds that fall under the above formula »da. the other connections can be made in exactly the same way »
example 1
. 6iiinex^ Suspension von 300 mg Triameinolon in 7,5 ml Dioxan ('getrocknet und neudestilliert) werden 2,5 g Kaproyloxyazeton und 25 wg 75:5^ige Perchlorsäure zugesetzt. Das Rcaktionsgeraisch wird 5 Stunden lang bei 20-30 C_ in Stickgasatmosphäre gerührt. Allmählich wird eine homogene saure Lösung gebildet, die mit 5^o Natriuiübikarbonatlösung auf pH 6,5 neutralMert wird. Die Lösung wird mit Chloroform extrahiert, wonach die Chloroformschicht getrocknet und im Vakuum eingedunstet wird. Das Reaktionsprodukt wird aus ca. 10 ml einer Mischung von Äthyläzetat und Ligroin im Verhältnis i:i urakristallisiert,. Das Triaincinolonkaproyloxyazetonid erhält man mit einer Ausbeute von 82$ und einem Schmelzpunkt von 229 -. 6 iiinex ^ suspension of 300 mg of triameinolone in 7.5 ml of dioxane ('dried and redistilled) 2.5 g of caproyloxyacetone and 25 % of 75: 5% perchloric acid are added. The reaction device is stirred for 5 hours at 20-30 ° C. in a nitrogen gas atmosphere. Gradually a homogeneous acidic solution is formed, which is neutralized to pH 6.5 with 5% sodium bicarbonate solution. The solution is extracted with chloroform, after which the chloroform layer is dried and evaporated in vacuo. The reaction product is uracrystallized from approx. 10 ml of a mixture of ethyl acetate and ligroin in the ratio i: i. The Triaincinolonkaproyloxyazetonid is obtained with a yield of $ 82 and a melting point of 229 -
Aus nachstehender Tabelle gehen die Schmelzpunkte der Verbindungen hervor, die unter die vorhergehende allgemeine Formel fallen.The following table shows the melting points of the Connections emerge under the previous general Fall formula.
-3 --3 -
009844/1793009844/1793
Corticosteroidderivate nach R. X SclinieΙζχ)unkt vorstehender Formel CCorticosteroid derivatives according to R. X SclinieΙζχ) item formula C above
Triamciholonbutyroyloxyazetonid Triamcinolonvaleroyloxyazetonid TriamcinolonkaproyloxyazetonidTriamciholonbutyroyloxyazetonide Triamcinolone valeroyloxyazetonide triamcinolone caproyloxyazetonide
Triameinolori-3,3,dimethylbutyroyloxyazetonid Triameinolori-3,3, dimethylbutyroyloxyazetonide
FluocinolonvaleroyloxyazetonidFluocinolone valeroyloxyacetonide
Der antiinflammatorische Effekt bei den Substanzen der Tabelle 1 ist mit Triamcinolgnacetyloxyaze$iid nach vorstehend genannten Patenten durch den Granulomtest, vgl. Experientia 6, 1950, Seiten 469 — 471, an adrenalektomisierten Mäusen, d.h. Mäusen mit wegoperierten Nebennieren, verglichen worden. Dieses ist an zwei Gruppen von Versuchstieren durchgeführt worden. Der einen Tiergruppe ist subkutan eines der Corticosteroide nach Tabelle 1 zugeführt worden, während die andere Gruppe zur Kontrolle diente. Danach wurden die Gewichtszunahmen der verwendeten "cott.onpellets-" bei den Tieren, die Corticosteroid erhalten haben, mit den Tieren verglichen, die keine Behandlung mit Corticosteroid erhalten haben. Die Ergebnisse .in den genannten Versuchen werden in nachstehender Tabelle zusammengefaßt:The anti-inflammatory effect of the substances in Table 1 is with Triamcinolgnacetyloxyaze $ iid according to the above Patents by the granuloma test, see Experientia 6, 1950, pp 469-471, on adrenalectomized mice, i.e. mice with removed adrenal glands. This has been carried out on two groups of test animals. The one In the animal group, one of the corticosteroids according to Table 1 was administered subcutaneously, while the other group served as controls. Thereafter, the weight increases of the "cott.onpellets" used in the animals that received corticosteroid with the Compared animals not receiving corticosteroid treatment. The results in the experiments mentioned will be summarized in the following table:
BAD ORIGINAL 0 9 8 4 4/1793BAD ORIGINAL 0 9 8 4 4/1793
dosis
in mgDaytime
dose
in mg
Tiereanimals
% des Granulomge- % of the granuloma
wichtes der Verweight of ver
suchstiere.search bulls.
Qxyacetonid "Triameinolone *} * 3-dimethylbutyroyl-
Qxyacetonide "
oxyacetonidTriamcinolone - ^^ - ciinietylbutyroyl-
oxyacetonide
Aus dem vorstehenden geht klar und deutlich hervor, dass die Valeroyloxyacetonide im Verhältnis zu den übrigen Verblndungpri einen nachweisbarbesseren antlinflammatorischenEffekt haben<.From the foregoing it is clear that the Valeroyloxyacetonide in relation to the other compound products have a demonstrably better anti-inflammatory effect <.
Claims (4)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1048/66A SE307576B (en) | 1966-01-27 | 1966-01-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1618028A1 true DE1618028A1 (en) | 1970-10-29 |
Family
ID=20257516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19671618028 Pending DE1618028A1 (en) | 1966-01-27 | 1967-01-05 | Process for the preparation of methylacyloxymethyl ketals from prednisolone derivatives with 3 to 5 carbon atoms in the acyl group |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3524850A (en) |
| AT (1) | AT269385B (en) |
| BE (1) | BE692983A (en) |
| CH (1) | CH487872A (en) |
| DE (1) | DE1618028A1 (en) |
| ES (1) | ES336470A1 (en) |
| FR (1) | FR6257M (en) |
| GB (1) | GB1120337A (en) |
| GR (1) | GR33327B (en) |
| NL (1) | NL6700465A (en) |
| SE (1) | SE307576B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2278122C1 (en) * | 2004-12-27 | 2006-06-20 | Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) | 9α-FLUORO-16α-HYDROXYPREDNISOLON [3H]-ACETONIDE HIGHLY LABELED WITH TRITIUM |
| WO2011029547A2 (en) * | 2009-09-11 | 2011-03-17 | Chiesi Farmaceutici S.P.A. | Pregnane derivatives condensed in the 16, 17 position with an n-substituted isoxazolidine ring as anti-inflammatory agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3048581A (en) * | 1960-04-25 | 1962-08-07 | Olin Mathieson | Acetals and ketals of 16, 17-dihydroxy steroids |
| US3341526A (en) * | 1965-01-12 | 1967-09-12 | Bofors Ab | Acyloxyacetals of fluoro-16alpha-hydroxyprednisolones |
-
1966
- 1966-01-27 SE SE1048/66A patent/SE307576B/xx unknown
-
1967
- 1967-01-05 DE DE19671618028 patent/DE1618028A1/en active Pending
- 1967-01-12 NL NL6700465A patent/NL6700465A/xx unknown
- 1967-01-18 US US610010A patent/US3524850A/en not_active Expired - Lifetime
- 1967-01-19 AT AT52967A patent/AT269385B/en active
- 1967-01-20 BE BE692983D patent/BE692983A/xx unknown
- 1967-01-24 ES ES336470A patent/ES336470A1/en not_active Expired
- 1967-01-24 CH CH101267A patent/CH487872A/en not_active IP Right Cessation
- 1967-01-25 GR GR670133327A patent/GR33327B/en unknown
- 1967-01-26 GB GB3976/67A patent/GB1120337A/en not_active Expired
- 1967-01-26 FR FR92659A patent/FR6257M/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| GB1120337A (en) | 1968-07-17 |
| US3524850A (en) | 1970-08-18 |
| ES336470A1 (en) | 1970-04-01 |
| NL6700465A (en) | 1967-07-28 |
| FR6257M (en) | 1968-08-19 |
| SE307576B (en) | 1969-01-13 |
| BE692983A (en) | 1967-07-03 |
| GR33327B (en) | 1967-11-23 |
| AT269385B (en) | 1969-03-10 |
| CH487872A (en) | 1970-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH635594A5 (en) | METHOD FOR PRODUCING NEW GONA 4.9 (10) SERVICES. | |
| DE2318767C3 (en) | Triamcinolone derivative, process for its preparation and medicinal product containing it | |
| DE1618028A1 (en) | Process for the preparation of methylacyloxymethyl ketals from prednisolone derivatives with 3 to 5 carbon atoms in the acyl group | |
| DE3336292A1 (en) | NEW DICHLOR DERIVATIVES OF THE 16 (ALPHA) METHYLPREGNAN SERIES, THEIR PRODUCTION, THEIR USE AS MEDICINAL PRODUCTS AND THE COMPOSITIONS CONTAINING THEM | |
| DE1618993B1 (en) | Process for the preparation of 3- (2'-chloroethylthio) -6-formyl steroids | |
| DE2852055C2 (en) | ||
| DE1793600A1 (en) | Process for making steroid compounds | |
| DE1188079B (en) | Process for the preparation of 17alpha, 21-dioxysteroids | |
| CH494218A (en) | 3-Oximino-androstenes and gonenes | |
| DE2630270A1 (en) | 21-ACETALS AND MIXED 21-ACETALS OF STEROID-21-ALDEHYDE, INTERMEDIATE PRODUCTS AND METHOD FOR MANUFACTURING THE SAME | |
| DE1193941B (en) | Process for the preparation of therapeutically effective 16beta-alkyl-9alpha-fluoro-11beta, 17alpha, 21-trioxy-4-pregnen-3, 20-dione-21-acylates or the corresponding 2 | |
| DE1618917C3 (en) | 6 alpha, 21-difluorosteroids and processes for their production | |
| AT216151B (en) | Process for the preparation of deserpidic acid esters | |
| DE1668859C (en) | 6 alpha, 9 alpha difluorohydrocortisone or prednisolone 17 valerate | |
| DE1568216C (en) | Cardenohd digitoxoside carrying cyclic ethers in position 3,4 and process for their preparation | |
| DE1593204C (en) | 19-nor-delta high 4,6 -3,20-diketosteroids, process for their preparation and pharmaceuticals | |
| DE2056512C3 (en) | ||
| DE3028255A1 (en) | NEW HALOGEN DERIVATIVE FROM THE 16 ALPHA METHYLPREGNAN RANGE, ITS PRODUCTION, ITS USE AS MEDICINAL PRODUCTS AND THE COMPOSITIONS CONTAINING IT | |
| AT249865B (en) | Process for the preparation of new pyrazole compounds of the pregnane series | |
| DE1618662C3 (en) | 6-substituted 16alpha-methyl-4-pregnen- or 4,6-pregnadien-3betaol-20-one compounds, processes for their production and pharmaceutical preparations containing them | |
| DE1568219C3 (en) | Acovenoside A derivatives and processes for their preparation | |
| DE1668859B1 (en) | 6alpha, 9alpha-difluorohydrocortisone or prednilon-17-valerate | |
| DE1618993C (en) | Process for the preparation of 3- (2-chloroethylthio) -6-formyl steroids | |
| DE977228C (en) | Process for the production of new, low-melting esters of steroid hormones | |
| DE1808425C (en) | 3 Oxo 17beta hydroxy 17 alpha (but 2 myl> 13 beta C deep 1 to C deep 3 alkyl gona 4,9,11 tnene |